Guided Therapeutics (GTHP) Return on Capital Employed Growth (5y) (2017 - 2025)
Guided Therapeutics (GTHP) Return on Capital Employed Growth (5y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.33 Bn | 174.04 Bn | 6.27 Bn |
| 2 | Stryker | 128.11 Bn | 125.23 Bn | 3.81 Bn |
| 3 | Medtronic | 107.76 Bn | 98.54 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.95 Bn | 66.50 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.43 Bn | 26.14 Bn | 1.98 Bn |
| 7 | Dexcom | 28.31 Bn | 27.20 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.77 Bn | 26.19 Bn | - |
| 9 | Koninklijke Philips | 25.33 Bn | 22.21 Bn | 2.07 Bn |
| 10 | Guided Therapeutics | 20.39 Mn | 20.32 Mn | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,918.00 |
| Sep 30, 2025 | 2,665.00 |
| Jun 30, 2025 | 2,981.00 |
| Mar 31, 2025 | 3,487.00 |
| Dec 31, 2024 | 3,552.00 |
| Sep 30, 2024 | 3,236.00 |
| Jun 30, 2024 | 3,757.00 |
| Mar 31, 2024 | 6,645.00 |
| Dec 31, 2023 | 9,925.00 |
| Sep 30, 2023 | 12,606.00 |
| Jun 30, 2023 | 17,087.00 |
| Mar 31, 2023 | 40,159.00 |
| Dec 31, 2022 | 23,860.00 |
| Sep 30, 2022 | 8,036.00 |
| Jun 30, 2022 | 1,956.00 |
| Mar 31, 2022 | 1,868.00 |
| Dec 31, 2021 | 1,012.00 |
| Sep 30, 2021 | 128.00 |
| Jun 30, 2021 | -4,349.00 |
| Mar 31, 2021 | -14,811.00 |